NTRK2 and Alzheimer disease: Interestingly, in AD, TrkB.T1 levels increase while BDNF and full-length TrkB levels in the frontal cortex and hippocampus decrease, and these elevated levels of TrkB.T1 also correlate with memory and cognitive impairments in transgenic mouse models of AD [65,132,154].